SCHEMBL8794840

SCHEMBL8794840

CC(=O)Nc1c(Cl)cc(O)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
ALDH1A1 P00352 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 3/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA9 Q16790 2/20 0.43
MAPT P10636 2/20 0.43
CA12 O43570 1/20 0.43
BRD4 O60885 1/20 0.43
NR1I2 O75469 1/20 0.43
MB P02144 1/20 0.43
CYP1A1 P04798 1/20 0.43
CA3 P07451 1/20 0.43
RARG P13631 1/20 0.43
TSHR P16473 1/20 0.43
ALOX5AP P20292 1/20 0.43
CA4 P22748 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9031190 0.84 ALDH1A1 (0.49) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL7264596 0.83 KMT2A (0.54) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL1285464 0.81 MAPT (0.46) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL8773869 0.81 POLB (0.41) LMNAALDH1A1KMT2AMEN1CA1
SCHEMBL7810225 0.81 CA1 (0.45) LMNAALDH1A1CYP3A4KMT2AMEN1
SCHEMBL10471341 0.79 TTR (0.52) LMNAALDH1A1KMT2AMEN1MAPT
SCHEMBL6025981 0.78 BACE1 (0.43) ALDH1A1KMT2AMEN1TSHRBACE1
SCHEMBL11611125 0.78 ALDH1A1 (0.41) LMNAALDH1A1CYP1A2KMT2AMEN1
SCHEMBL14221326 0.78 BACE1 (0.38) LMNAALDH1A1CYP1A2KMT2AMEN1
SCHEMBL9528503 0.78 USP2 (0.45) LMNAALDH1A1CYP1A2MAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0611003-B1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO INC (US) 1997-06-18 EP disclosed
US-5451677-A Substituted phenyl sulfonamides as selective β 3 agonists for the treatment of diabetes and obesity MERCK & CO., INC. (US) 1995-09-19 US disclosed
WO-1994018161-A1 SUBSTITUTED PHENYL SULFONAMIDES AS SELECTIVE β3 AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY MERCK & CO., INC. (US) 1994-08-18 WO disclosed
EP-0611003-A1 Substituted phenyl sulfonamides as selective B3 agonists for the treatment of diabetes and obesity MERCK & CO. INC. (US) 1994-08-17 EP disclosed
US-5288756-A Pesticides, miticides, larvicides; nontoxic to warm blood animals CIBA-GEIGY CORPORATION (US) 1994-02-22 US disclosed
EP-0219460-B1 BENZOYLPHENYL UREAS CIBA-GEIGY AG (CH) 1991-05-02 EP disclosed
EP-0219460-A2 Benzoylphenyl ureas CIBA-GEIGY AG (CH) 1987-04-22 EP disclosed